Limitations of exome sequencing in detecting rare and undiagnosed diseases
- 19 March 2020
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 182 (6), 1400-1406
- https://doi.org/10.1002/ajmg.a.61558
Abstract
While exome sequencing (ES) is commonly the final diagnostic step in clinical genetics, it may miss diagnoses. To clarify the limitations of ES, we investigated the diagnostic yield of genetic tests beyond ES in our Undiagnosed Diseases Network (UDN) participants. We reviewed the yield of additional genetic testing including genome sequencing (GS), copy number variant (CNV), noncoding variant (NCV), repeat expansion (RE), or methylation testing in UDN cases with nondiagnostic ES results. Overall, 36/54 (67%) of total diagnoses were based on clinical findings and coding variants found by ES and 3/54 (6%) were based on clinical findings only. The remaining 15/54 (28%) required testing beyond ES. Of these, 7/15 (47%) had NCV, 6/15 (40%) CNV, and 2/15 (13%) had a RE or a DNA methylation disorder. Thus 18/54 (33%) of diagnoses were not solved exclusively by ES. Several methods were needed to detect and/or confirm the functional effects of the variants missed by ES, and in some cases by GS. These results indicate that tests to detect elusive variants should be considered after nondiagnostic preliminary steps. Further studies are needed to determine the cost‐effectiveness of tests beyond ES that provide diagnoses and insights to possible treatment.Keywords
Funding Information
- NIH Common Fund (UO1HG007674)
This publication has 35 references indexed in Scilit:
- Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditionsGenetics in Medicine, 2015
- Disruptions of Topological Chromatin Domains Cause Pathogenic Rewiring of Gene-Enhancer InteractionsCell, 2015
- Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variantsProceedings of the National Academy of Sciences of the United States of America, 2015
- Clinical Exome Sequencing for Genetic Identification of Rare Mendelian DisordersJAMA, 2014
- Molecular Findings Among Patients Referred for Clinical Whole-Exome SequencingJAMA, 2014
- Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian DisordersThe New England Journal of Medicine, 2013
- Copy-Number Variations, Noncoding Sequences, and Human PhenotypesAnnual Review of Genomics and Human Genetics, 2011
- Copy number variants, diseases and gene expressionHuman Molecular Genetics, 2009
- Side effects of genome structural changesCurrent Opinion in Genetics & Development, 2007
- Variation in FTO contributes to childhood obesity and severe adult obesityNature Genetics, 2007